BRCA1 and BRCA2 play similar roles in the above cancer types, however their predictive significance for prostate cancer is distinct: indeed, mainly BRCA2 but not BRCA1 germline mutations are accompanied by somatic loss of the wild-copy of the gene and consequent sensitivity to PARPis [114,115]. This evidence concerns the gene BRCA1 and prostate carcinoma.